125 results on '"Mohammed, Shvan H."'
Search Results
102. Retroperitoneal lipoma; a benign condition with frightening presentation
- Author
-
Al-Ali, Mohammad Hasan M., primary, Salih, Abdulwahid M., additional, Ahmed, Okba F., additional, Kakamad, Fahmi H., additional, Mohammed, Shvan H., additional, Hassan, Marwan N., additional, Sidiq, Shadi H., additional, Mustafa, Mohammed Q., additional, Najar, Kayhan A., additional, and Abdullah, Ismael Y., additional
- Published
- 2019
- Full Text
- View/download PDF
103. Solid pseudopapillary tumor of the pancreas in a 17-year-old girl
- Author
-
Mohammed, Ayad Ahmad, primary, Rasheed, Ferhad Mohammed, additional, Arif, Sardar Hassan, additional, Salih, Abdulwahid M., additional, Kakamad, Fahmi H., additional, and Mohammed, Shvan H., additional
- Published
- 2019
- Full Text
- View/download PDF
104. Fibrolipoma of the tongue; a case report with literature review
- Author
-
Salih, Abdulwahid M., Abdullah, Ari M., Fatah, Mariwan L., Abdulla, Berwn A., Mohammed, Shvan H., and kakamad, Fahmi H.
- Published
- 2021
- Full Text
- View/download PDF
105. Double cystic duct, a review of literature with report of a new case
- Author
-
Salih, Abdulwahid M., primary, Kakamad, F.H., additional, Mohammed, Shvan H., additional, Salih, Rawezh Q., additional, Habibullah, Imad J., additional, Muhialdeen, Aso S., additional, and Fatih, Hiwa, additional
- Published
- 2017
- Full Text
- View/download PDF
106. Extra‑abdominal recurrent aggressive fibromatosis: A case series and a literature review.
- Author
-
Asaad, Saywan K., Abdullah, Ari M., Abdalrahman, Shkar Ali, Fattah, Fattah H., Tahir, Soran H., Omer, Choman Sabah, Rashid, Rezheen J., Hassan, Marwan N., Mohammed, Shvan H., Kakamad, Fahmi H., and Abdalla, Berun A.
- Subjects
DESMOID tumors ,LITERATURE reviews ,SURGICAL margin ,TUMOR surgery ,FIBROMAS ,GIANT cell tumors - Abstract
Aggressive fibromatosis is a rare clonal proliferative tumor arising from mesenchymal cells in the fascia and musculoaponeurotic structures. The aim of the present study was to describe several cases of extra-abdominal recurrent aggressive fibromatosis. The present study was a single-center retrospective case series of patients with recurrent aggressive fibromatosis. The cases were managed at a single private facility. A total of 9 patients with recurrent fibromatosis were included. The mean and median ages of the patients were 29 and 30 years, respectively. In total, two thirds (66.67%) of the cases were female. A negative previous medical history was reported in 7 cases (77.7%), and diabetes and hypertension were reported in 1 case (11.1%). Overall, only 1 case (11.1%) had a family history of breast fibromatosis. The time interval between primary tumor resection and recurrent presentation was 28 months. In 6 cases (66.7%), the tumor was located in the extremities. Pain was the most common presenting symptom in 6 cases (66.7%). All patients had their recurring tumor surgically removed, followed by radiation in 5 cases. The resection margin was positive in 4 cases (44.4%). Each patient was subjected to a careful three-month follow-up for recurrences. On the whole, the present study demonstrates that despite the fact that several therapeutic approaches for extra-abdominal recurrent aggressive fibromatosis have been described in the literature, there is a significant likelihood of recurrence following resection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
107. Prognostic factors in renal cell carcinoma: A single‑center study.
- Author
-
Ali, Rawa M., Muhealdeen, Dana N., Fakhralddin, Saman S., Bapir, Rawa, Tahir, Soran H., Rashid, Rezheen J., Omer, Choman Sabah, Abdullah, Hiwa O., Abdalla, Berun A., Mohammed, Shvan H., Kakamad, Fahmi H., Abdullah, Fakher, Karim, Muhammad, and Rahim, Hawbash M.
- Subjects
PROGNOSIS ,OVERALL survival ,CANCER relapse ,SURVIVAL rate ,DISEASE progression - Abstract
Renal cell carcinoma (RCC) is a heterogeneous and complex disease with numerous pathophysiologic variants. ~40% of patients succumb due to the progression of the disease, making RCC the most fatal of the common urologic malignancies. Prognostic factors are indicators of the progression of the disease, and the precise determination of these factors is important for evaluating and managing RCC. In the present study, it was aimed to determine and find associations among the histopathological features of RCCs and their impact on survival and metastasis. This is a cross-sectional study of RCC cases who have undergone partial or radical nephrectomy from March 2008 to October 2021 and have been pathologically reviewed at Shorsh General Teaching Hospital in Sulaimani, Iraq. The data in the pathology studies were supplemented by follow-up of the patients to obtain information about survival, recurrence and metastasis. In total, 228 cases of RCC were identified, among whom 60.5% were men and 39.5% were women, with a median age of 51 years. The main tumor types were clear cell RCC (71.1%), papillary RCC (13.6%), and chromophobe RCC (11%). Various measures of aggressiveness, including tumor necrosis, sarcomatoid change, microvascular invasion, and parameters of invasiveness (invasion of the renal sinus and other structures), were significantly correlated with each other, and they were also associated with reduced overall survival and an increased risk of metastasis on univariate analysis. However, on multivariate analysis, only tumor size and grade, and microvascular invasion retained statistical significance and were associated with a lower survival rate. In conclusion, pathological parameters have an impact on prognosis in RCC. The most consistent prognostic factors can be tumor size and grade, and microvascular invasion. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
108. Resectability in bronchogenic carcinoma: A single‑center experience.
- Author
-
Marie, Mohammed Mowafaq, Jaber, Sabah N., Ahmed, Okba F., Kakamad, Fahmi H., Amin, Bnar J. Hama, Tahir, Soran H., Salih, Abdulwahid M., Abdalla, Shalaw H., Ali, Razhan K., Rashid, Rezheen J., Mohammed, Shvan H., Mustafa, Shevan M., Ali, Rebwar A., and Rahim, Hawbash M.
- Subjects
BRONCHIAL carcinoma ,SPUTUM examination ,NEEDLE biopsy ,SMALL cell lung cancer ,VIDEO-assisted thoracic surgery ,MINIMALLY invasive procedures - Abstract
Bronchogenic carcinoma comprises >90% of primary lung tumors. The present study aimed to estimate the profile of patients with bronchogenic carcinoma and assess the cancer resectability in newly diagnosed patients. This is a single-center retrospective review conducted over a period of 5 years. A total of 800 patients with bronchogenic carcinoma were included. The diagnoses were mostly proven with either cytological examination or histopathological diagnosis. Sputum analysis, cytological examination of pleural effusion and bronchoscopic examination were performed. Lymph node biopsy, minimally invasive procedures (mediastinoscopy and video-assisted thoracoscopic surgery), tru-cut biopsy or fine-needle aspiration was used to obtain the samples for diagnosis. The masses were removed by lobectomy and pneumonectomy. The age range was between 22 and 87 years, with a mean age of 62.95 years. Males represented the predominant sex. Most of the patients were smokers or ex-smokers. The most common symptom was a cough, followed by dyspnea. Chest radiography revealed abnormal findings in 699 patients. A bronchoscopic evaluation was performed for the majority of patients (n=633). Endobronchial masses and other suggestive malignancy findings were present in 473 patients (83.1%) of the 569 who underwent fiberoptic bronchoscopy. Cytological and/or histopathological samples of 581 patients (91.8%) were positive. Small cell lung cancer (SCLC) occurred in 38 patients (4.75%) and non-SCLC was detected in 762 patients (95.25%). Lobectomy was the main surgical procedure, followed by pneumonectomy. A total of 5 patients developed postoperative complications without any mortality. In conclusion, bronchogenic carcinoma is rapidly increasing without a predilection for sex in the Iraqi population. Advanced preoperative staging and investigation tools are required to determine the rate of resectability. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
109. Synchronous ipsilateral papillary renal cell carcinoma and urothelial carcinoma: A case report.
- Author
-
Babarasul, Muhamed Hussen, Bapir, Rawa, Rahman, Dalshad Hama Khurshid, Fakhralddin, Saman Salih, Kakamad, Fahmi H., Tahir, Soran H., Ali, Rawa M., Abdalla, Berun A., Mohammed, Shvan H., and Hussein, Dlsoz M.
- Subjects
RENAL cell carcinoma ,TRANSITIONAL cell carcinoma ,KIDNEY pelvis ,TUMOR classification ,DELAYED diagnosis - Abstract
Concurrence of renal cell carcinoma (RCC) and urothelial carcinoma (UC) in the same kidney is a rare phenomenon. It is critical to define this unusual disease to avoid a delay in diagnosis and improve the prognosis. The present study describes a case of a 71-year-old patient with synchronous ipsilateral RCC and UC of the renal pelvis and ureter. The patient presented with intermittent attacks of left loin pain with frank hematuria for 3 months and a weight loss of 5 kg over the same period of time. The patient had been a chronic heavy smoker for >45 years. Physical examination revealed stable vital signs; however, a mobile, non-tender mass was palpated in the left upper abdomen. A left nephroureterectomy with the removal of a bladder cuff was performed. Histopathological examination revealed a papillary RCC with a pathological stage of pT1N0Mx and a high-grade UC of the renal pelvis and ureter with a pathological stage of pT3-pN1-pMx. The postoperative recovery was good, and the patient was referred to an oncology center for further management. Previous reports have failed to identify definitive risk factors for the concurrence of RCC and UC. However, 24% of the patients in the various case reports in the literature were smokers. The most common presenting complaints included weight loss and painless hematuria. The concurrence of RCC and UC in the same kidney is a rare entity, and it frequently leads to a worse prognosis than the occurrence of RCC alone. Radical nephroureterectomy is the main line of treatment for patients with upper tract UC. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
110. Whole‑body MRI for metastatic workup in patients diagnosed with cancer.
- Author
-
Rashid, Rezheen J., Tahir, Soran H., Kakamad, Fahmi H., Omar, Sami S., Salih, Abdulwahid M., Ahmed, Shaho F., Abdalla, Shalaw H., Naqar, Sharo, Salih, Rawezh Q., Kakamad, Suhaib H., Mohammed, Karukh K., Mustafa, Shevan M., Hassan, Marwan N., and Mohammed, Shvan H.
- Subjects
CANCER diagnosis ,LYMPHATIC metastasis ,LIVER metastasis ,CANCER patients ,MAGNETIC resonance imaging - Abstract
Early diagnosis and appropriate staging workup are crucial for cancer patients. Whole-body magnetic resonance imaging (WB-MRI) has been proposed as another practical whole-body approach for assessing local invasiveness and distant metastases in patients newly diagnosed with cancer. The current study aimed to evaluate the efficacy of WB-MRI in assessing metastasis in patients newly diagnosed with cancer using histopathologic data as the reference method. A prospective observational study was performed from April 2018 to July 2020. MRI sequences were utilized to acquire anatomical and functional images in three orthogonal planes. The discovery was classified as nodal, skeletal and visceral metastases. Patient-based analysis was used for visceral metastasis and region-based for skeletal, systemic and lymph node metastases. A total of 43 consecutive patients (mean age, 56±15.2 years) were assessed successively. In 41 patients, there was a concordance between the WB-MRI and histological confirmation. The most prevalent site of metastasis was the skeletal system (18 patients). There were 12 individuals with liver metastasis, 10 with lung metastasis and 4 with peritoneal metastasis, with just one brain metastatic lesion found. On WB-MRI, 38 lymph node groups were deemed positive. Out of the total, 66 skeletal locations contained metastases. The accuracy of WB-MRI for nodal, skeletal and visceral metastases was (98.45, 100 and 100%, respectively). In conclusion, WB-MRI in three orthogonal planes, including the diffusion-weighted MRI with background body signal suppression sequence, may be utilized efficiently and accurately for assessing metastasis staging and may thus be utilized in patients with newly diagnosed cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
111. Renal cell carcinoma T staging: Diagnostic accuracy of preoperative contrast-enhanced computed tomography.
- Author
-
Fateh, Salah M., Arkawazi, Lusan A., Tahir, Soran H., Rashid, Rezheen J., Rahman, Dalshad H., Aghaways, Ismaeel, Kakamad, Fahmi H., Salih, Abdulwahid M., Bapir, Rawa, Fakhralddin, Saman S., Fattah, Fattah H., Abdalla, Berun A., and Mohammed, Shvan H.
- Subjects
COMPUTED tomography ,VENA cava inferior ,RENAL veins ,T cells ,KIDNEY tumors ,TUMOR classification - Abstract
Renal cell carcinoma (RCC) accounts for 1-2% of all malignancies and is the most common renal tumor in adults. Imaging studies are used for diagnosis and staging. Tumor-Node-Metastasis staging strongly affects prognosis and management, while contrast-enhanced computed tomography (CECT) is regarded as a standard imaging technique for local and distant staging. The present study aimed to evaluate the accuracy of CECT for the preoperative staging of RCC by using surgical and pathological staging as the reference methods. This single-center prospective study was conducted between October 2019 and November 2021. The preoperative abdominal CT scans of patients suspected of having RCC were reviewed. Imaging data were collected, including tumor side and size, and perinephric fat invasion. Intraoperative notes were recorded, including the operation type, perinephric fat invasion, renal vein (RV) or inferior vena cava (IVC) tumor extension, and surrounding organ invasion. pathological data were collected on tumor size, RCC type, presence of clear margins, presence of renal capsule or perinephric fat invasion, renal sinus or pelvicalyceal system (PCS) invasion, segmental or main RV extension, and the involvement of Gerota's fascia and nearby organs. Preoperative CECT revealed that 42 out of 59 tumors had a greater maximum diameter than the pathological specimen, with an overall disparity of 0.25 cm. The specificity of CT for the detection of tumor invasion of the perinephric and renal sinus fat and PCS was 95%, and the sensitivity ranged from 80 to 88%. CT had an 83% sensitivity and a 95 specificity in detecting T4 stage cancer, with a 100% specificity for adrenal invasion. The concordance between radiographic and histological results for RV and IVC involvement was high, with specificities of 94 and 98%, and sensitivities of 80 and 100%, respectively. Overall accuracy for correct T staging was 80%. In conclusion, CECT is accurate in the local T staging of RCC, with high sensitivity and specificity for estimating tumor size and detecting extension to nearby structures and venous invasion. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
112. Conjunctival attachment of a live tick (Ixodesspecies) in an infant: a rare case report with literature review
- Author
-
Mohammed, Rawand F., Abdulla, Berun A., Mohammed, Shvan H., Salih, Rawezh Q., Abdullah, Hiwa O., Salih, Abdulwahid M., Kakamad, Fahmi H., and Noori, Savo Sh.
- Published
- 2022
- Full Text
- View/download PDF
113. Post COVID-19 pulmonary fibrosis; a meta-analysis study
- Author
-
Hama Amin, Bnar J., Kakamad, Fahmi H., Ahmed, Gasha S., Ahmed, Shaho F., Abdulla, Berwn A., mohammed, Shvan H., Mikael, Tomas M., Salih, Rawezh Q., Ali, Razhan k., Salh, Abdulwahid M., and Hussein, Dahat A.
- Abstract
Introduction; Pulmonary fibrosis is a frequently reported COVID-19 sequela in which the exact prevalence and risk factors are yet to be established. This meta-analysis aims to investigate the prevalence of post-COVID-19 pulmonary fibrosis (PCPF) and the potential risk factors.
- Published
- 2022
- Full Text
- View/download PDF
114. The relationship between CT severity infections and oxygen saturation in patients infected with COVID-19, a cohort study
- Author
-
Qadir, Faraidoon I., Kakamad, Fahmi H., Abdullah, Ismael Y., Abdulla, Berwn A., Mohammed, Shvan H., Salih, Rawezh Q., Ali, Razhan K., and Salh, Abdulwahid M.
- Abstract
Thin-section chest computed tomography is an important diagnostic test and utilized to determine the severity of lung involvement in COVID-19 pneumonia. The goal of this study is to examine the relationship between CT severity and the oxygen saturation level of individuals with COVID-19.
- Published
- 2022
- Full Text
- View/download PDF
115. Post COVID – 19 neurological disorders; a single center experience; a case series
- Author
-
Ahmad, Shwan A., Mohammed, Shvan H., Abdulla, Berwn A., Salih, Bestoon Kh, Hassan, Marwan N., Salih, Abdulwahid M., Kakamad, Fahmi H., Abdullah, Hiwa O., Hassan, Hemn Ali, Othman, Snur, and Sidiq, Shadi Hamid
- Abstract
Coronavirus disease 2019 (COVID-19) pandemic, is a newly conducted respiratory disease caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). The current study aims to estimate the neurological diseases which develop after COVID-19 infection.
- Published
- 2022
- Full Text
- View/download PDF
116. COVID-19 associated with pulmonary mucormycosis; a case series
- Author
-
Ahmed, Okba F., Al-Neaimy, Saoud, Kakamad, Fahmi H., Ali, Razhan k., Mikael, Tomas M., Hamasaeed, Ahmed Gh, mohammed, Shvan H., Salih, Rawezh Q., Salh, Abdulwahid M., and Hamasaeed, Muhammed Gh
- Abstract
Coronavirus disease 2019 (COVID-19) has evolved as a result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). With the rise of cases worldwide, plenty of potential COVID-19 complications have emerged, including increased susceptibility to subsequent bacterial and fungal infections. This study aims to report four cases of COVID-19 associated with pulmonary mucormycosis.
- Published
- 2022
- Full Text
- View/download PDF
117. Thyroid collision tumors; A case series with literature review
- Author
-
Abdullah, Ari M., Qaradakhy, Aras J., Ahmed, Mohsin M., Salih, Abdulwahid M., Omar, Sami S., Kakamad, Fahmi H., Rahim, Hawbash M., Abdulla, Berwn A., Mohammed, Shvan H., Ahmed, Shaho F., Baba, Hiwa O., and Ishaac, Rivan Hermiz
- Abstract
Collision tumors are two histologically distinct types of malignancies within the same mass and organ. The aim of this study is to present a case series of thyroid collisions.
- Published
- 2022
- Full Text
- View/download PDF
118. Role of autologous blood patch pleurodesis for management of prolonged pulmonary air leak: A systematic review.
- Author
-
Abdalla, Berun A., Kakamad, Fahmi H., Hassan, Marwan N., Muhialdeen, Asia Bahaaldeen, Ahmed, Farman J., Ahmed, Harem K., Kakamad, Suhaib H., Salih, Rawezh Q., Mohammed, Shvan H., Mustafa, Shevan M., Omar, Diyar A., Kareem, Pavel Mustafa, Hasan, Sabah Jalal, Mahmood, Yousif M., and Mustafa, Mohammed Q.
- Subjects
- *
BLOOD volume , *CHEST tubes , *PNEUMOTHORAX , *MEDLINE , *COHORT analysis , *PLEURODESIS - Abstract
Prolonged air leak (PAL) represents the most commonly encountered complication following pulmonary resection. This review aims to show the role of autologous blood pleurodesis (ABPP) in the management of PAL. A search was conducted on the Web of Science, PubMed, MEDLINE, and Google Scholar for English-language articles until September 15, 2023, with titles containing the related phrase "autologous blood patch pleurodesis (ABPP), and prolonged air leaks." Included studies comprised four randomised controlled trials, ten cohort studies, a case series, and nine case reports from various countries. Patients undergoing ABPP had a mean age of 52.7 years. Autologous blood volumes for pleurodesis varied (50 mL to 250 mL). Approximately 73.8% of cases responded to ABPP in 1 to 30 days (mean 3.75 days), and in-hospital complications were infrequent (3.9%). Follow-up durations post pleurodesis were up to 20 months. The evidence presented in this systematic review supports the role of ABPP as an effective and safe intervention for managing PAL, particularly after pulmonary resection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
119. Post COVID-19 neurological complications; a meta-analysis
- Author
-
Ahmed, Jaafar Omer, Ahmed, Shwan Abdubakr, Hassan, Marwan Nasih, Kakamad, Fahmi H., Salih, Rawezh Q., Abdulla, Berwn A., Rahim Fattah, Fattah Hama, Mohammed, Shvan H., Ali, Razhan K., and Salih, Abdulwahid M.
- Abstract
Despite numerous studies regarding neurological manifestations and complications of COVID-19, only a few cases of neurological consequences following complete recovery from SARS-CoV-2 infection have been described.
- Published
- 2022
- Full Text
- View/download PDF
120. Pediatric thoracic outlet syndrome: a systematic review with metadata.
- Author
-
Abdalla, Berun A., Kakamad, Fahmi H., Namiq, Hiwa Shafiq, Asaad, Saywan Kakarash, Abdullah, Aland S., Mustafa, Ayman M., Ghafour, Abdullah K., Kareem, Honar O., Ahmed, Samen Qadir Mohammed, Mohammed, Bilal A., Hasan, Karzan M., and Mohammed, Shvan H.
- Subjects
- *
THORACIC outlet syndrome , *CHILD patients , *METADATA , *PHYSICAL activity - Abstract
Introduction: Thoracic outlet syndrome (TOS) typically considered a condition of the adult population; it is often disregarded in children and adolescents due to its limited recognition within the pediatrics. The current study aims to systematically review and provide insights into TOS among pediatric patients. Methods: PubMed, Scopus, Web of Science, and Google Scholar databases were thoroughly searched for English language studies published until March 15th, 2024. The study included those articles focusing on pediatric or adolescent individuals diagnosed with TOS. Data collected from studies encompassed date of publication, number of participants or reported cases, age (years), gender of participants, type of TOS, affected side, type of treatment, surgical approach, bony abnormality, duration of symptoms (months), outcome, and follow-up time duration (months). Results: The current study comprised 33 articles, 21 of which were case reports, 10 of which were case series, and the remaining were cohort studies. In this study, 356 patients were included. Females constituted 234 (65.73%) of the patient population. Among TOS types, neurogenic TOS was found among 201 (56.5%) patients. Sporting-related activity or physical activity was present in 193 (54%) patients, followed by a history of trauma in 27 (7%) patients. Conclusions: Pediatric patients exhibited a higher percentage of vascular TOS than their adult counterparts, with the supraclavicular approach emerging as the preferred treatment method. Sports-related activities were identified as the primary risk factor associated with pediatric TOS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
121. Predictive value of inflammatory markers for the spontaneous passage of Ureteral stones: a comprehensive systematic review with meta analysis.
- Author
-
Bapir, Rawa, Fakhralddin, Saman S., Aghaways, Ismaeel, Muhammed, Bryar O., Rahim, Hawbash M., Fattah, Fattah H., Ismael, Barzan O., Ali, Rebaz E., Hamahussein, Karokh F., Kakamad, Fahmi Hussein, Salih, Rawezh Q., Mohammed, Shvan H., and Abdalla, Berun A.
- Subjects
- *
URINARY calculi , *URETER diseases , *CINAHL database , *CALCITONIN - Abstract
Urolithiasis is a common disease that affects approximately one-fifth of the global population. This systematic review explores the predictive role of inflammatory markers for the spontaneous passage of ureteral stones. The literature was systematically searched via Google Scholar, PubMed/MEDLINE, the Cochrane Library, Science Direct, CINAHL, Web of Science, and EMBASE databases to identify papers published until 2023. Overall, 26 articles were identified, of which 10 were excluded. The remaining 16 papers reported 2,695 patients (1,723 males and 972 females), with 1,654 (61.37%) experiencing spontaneous stone passage (SSP) and 1,041 (38.63%) not experiencing it (non-SSP). Stones located in the upper part of the ureter were less likely to pass spontaneously (152/959, 15.94% in the SSP group vs. 180/546, 32.48% in the non-SSP group; p < 0.001). Mid-ureteral stones were present in 180/959 (18.75%) of the SSP group compared to 84/546 (14.52%) of the non-SSP group (p = 0.0974). Lower ureteral stones were more likely to pass spontaneously, with 627/959 (63.31%) in the SSP group compared to 282/546 (49.36%) in the non-SSP group (p < 0.001). No significant correlation was found between most inflammatory markers and SSP (p > 0.05). However, procalcitonin levels were lower in the SSP group compared to the non-SSP group (132.7 ± 28.1 vs. 207 ± 145.1, respectively) (p < 0.001). This systematic review has revealed that except procalcitonin, most inflammatory markers do not offer significant predictive capability for ureteral SSP. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
122. Cardiac myxoma following transcatheter closure of an atrial septal defect.
- Author
-
Al-Modhaffer SS, Mohammed AA, Ahmed OF, Kakamad FH, Saeed DHM, Rahim HM, Hama JI, Mohammed HS, and Mohammed SH
- Abstract
To date, no significant association has been reported between atrial septal defects (ASD) and cardiac myxomas. This study reports a 56-year-old woman with cardiac myxoma following transcatheter closure of ASD. She presented with a 3-month history of recurrent dizziness, vertigo, palpitations, and generalized weakness after undergoing ASD occlusion a year earlier. Echocardiography and cardiac computed tomography scans identified a large, mobile mass (7.2 cm × 2.8 cm) in the left atrium, protruding through the mitral valve. The patient underwent median sternotomy and pericardiotomy, and the histopathological examination confirmed the diagnosis of atrial myxoma. The current case illustrates the challenges in determining whether an atrial mass is a benign myxoma or a dangerous thrombus. While there is no definitive link between the implantation of an ASD closure device and the formation of a myxoma, the emergence of this tumor is a potential occurrence., Competing Interests: All in control of content for this article report no financial relationships with ineligible companies. The authors report no funding. The patient consented to the publication of this report., (Copyright © 2024 Baylor University Medical Center.)
- Published
- 2024
- Full Text
- View/download PDF
123. Myocardial infarction following COVID-19 vaccine administration; a systematic review.
- Author
-
Baqi DH, Kakamad FH, Mahmood ZH, Fattah FH, Ahmed SF, Hassan MN, Hama Amin BJ, Mohammed SH, Mikael TM, Hassan HA, and Salh AM
- Abstract
Introduction: Covid-19 vaccines have been assessed in randomized trials, which are designed to establish efficacy and safety, but are insufficient in power to detect rare adverse outcomes. Among the adverse cardiac events associated with mRNA COVID-19 vaccines are inflammations (e.g., pericarditis or myocarditis), thrombosis, and ischemia., Objective: This systematic review aims to evaluate the reported cases of myocardial infarction (MI) after COVID-19 vaccinations., Method: Web of Science, MEDLINE on OVID, PubMed, and Google Scholar were searched for English-language papers published until March 25, 2022., Results: This study included 15 papers (10 case reports and 5 case series). In total, 20 individuals were included who had received COVID-19 vaccines and experienced MI. Males (55%) reported more adverse occurrences than females (45%) across the majority of event categories. The mean time from the administration of the vaccine to the onset of symptoms was 2 days (0-10 days). The AstraZeneca vaccine was responsible for more than half of the reported events. In the majority of cases, the event developed after receiving the first dose of vaccination., Conclusion: MI related to COVID19 vaccination is a rare, but serious and life-threatening condition. Chest discomfort should be regarded as a warning sign, particularly in people who have been administered a dose of the vaccine within the previous two days., Competing Interests: The authors declare no conflict of interest., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
124. Scarf pin inhalation; presentation and management; a case series.
- Author
-
Abduljabbar MA, Jabir SN, Ahmed OF, Kakamad FH, Salih AM, Mikael TM, Mohammed SH, Hassan HA, Hussein DA, Mustafa MQ, Salih RQ, and Omar DA
- Abstract
Background: Pin inhalation is an accidental entry of a pin into the respiratory passages. This study aims to shed the light on pin inhalation as a hazard and show the magnitude of such preventable thoracic problem and determine the safest method of management., Patients and Methods: This is a retrospective single center case series, conducted during 18 month period from January 2016 to April 2017, All patients with pin inhalation had been collected and analyzed according to the age, gender, time between aspiration to presentation and symptoms and signs, number of attempts, bronchoscopic or open removal of the pins with complications., Results: The total number of patients in this study was 162. The mean age was 11years. Pin inhalation accident was more common in patients less than 10 years in males and less than 20 years in females. The most common gender was female (73%). The most common presenting symptom was cough (54%). The left tracheobronchial tree was the most common site for pin lodgment 107 (67.3%) followed by the right side 23 (14.4%). The majority of the pins were extracted in one piece (94%). Thoracotomy was done in one patient, no death reported., Conclusion: Sharp pin inhalation is a serious hazard and can have lethal outcome. History is the major parameter to start the diagnosis of pin inhalation and radiography is the gold standard to confirm the diagnosis., Competing Interests: None to be declared., (© 2021 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
125. A severe refractory COVID-19 patient responding to convalescent plasma; A case series.
- Author
-
Abdullah HM, Hama-Ali HH, Ahmed SN, Ali KM, Karadakhy KA, Mahmood SO, Mahmood ZH, Hamad Amin KQ, Atta PM, Nuradeen BE, Mohammed SH, Salih RQ, Baba HO, and Kakamad FH
- Abstract
Introduction: Although some medicines are under research, currently, no specific antiviral drug has been approved to target 2019 novel coronavirus. In this report two severe cases of 2019 novel coronavirus disease (COVID-19) patients have been described who received convalescent plasma (CP)., Case Report: Two male cases (a 46-year-old and a 56-year-old) after being diagnosed with severe COVID-19, they deteriorated despite supportive care and antiviral therapy. They started to improve with CP infusion both clinically and radiologically. Finally they were discharged in a very well condition with negative virology tests., Conclusion: CP might be an effective therapy for severe COVID-19 patients., Competing Interests: None to be declared., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.